Increased ACE2 Expression as a Risk Factor for COVID-19

Decreased ACE2 Activity as a Risk Factor for the Severity of COVID-19

Inconsistencies in ACE2 Expression Hypotheses

Organs and Organ Systems Affected by COVID-19

Tissue ACE2 Expression Levels as Related to COVID-19 Symptoms

Effects of the ACE2 receptors on organ tissues of COVID-19 patients

ACE2 Protein and mRNA Expression in Tissue

ACE2 Expression in Adipose Tissue May Contribute to COVID-19 Morbidity and Mortality in Obese Patients

Graph of the Expression of ACE2 in Various Tissues